Search Results - "de Ceballos, María L"

Refine Results
  1. 1

    The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation by Innamorato, Nadia G, Rojo, Ana I, Garcia-Yague, Angel J, Yamamoto, Masayuki, de Ceballos, Maria L, Cuadrado, Antonio

    Published in The Journal of immunology (1950) (01-07-2008)
    “…Because chronic neuroinflammation is a hallmark of neurodegenerative diseases and compromises neuron viability, it is imperative to discover pharmacologic…”
    Get full text
    Journal Article
  2. 2

    Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation by Ramirez, Belen G, Blazquez, Cristina, del Pulgar, Teresa Gomez, Guzman, Manuel, de Ceballos, Maria L

    Published in The Journal of neuroscience (23-02-2005)
    “…Alzheimer's disease (AD) is characterized by enhanced beta-amyloid peptide (betaA) deposition along with glial activation in senile plaques, selective neuronal…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes by Pajares, Marta, Jiménez-Moreno, Natalia, García-Yagüe, Ángel J., Escoll, Maribel, de Ceballos, María L., Van Leuven, Fred, Rábano, Alberto, Yamamoto, Masayuki, Rojo, Ana I., Cuadrado, Antonio

    Published in Autophagy (02-10-2016)
    “…Autophagy is a highly coordinated process that is controlled at several levels including transcriptional regulation. Here, we identify the transcription factor…”
    Get full text
    Journal Article
  5. 5

    The GSK-3-inhibitor VP2.51 produces antidepressant effects associated with adult hippocampal neurogenesis by Pérez-Domper, Paloma, Palomo, Valle, Gradari, Simona, Gil, Carmen, de Ceballos, María L., Martínez, Ana, Trejo, Jose Luis

    Published in Neuropharmacology (01-04-2017)
    “…Glycogen synthase kinase 3 (GSK-3) is a constitutively active kinase that has been implicated in the mechanism of action of mood stabilizers. According to the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease by Martín-Moreno, Ana María, Reigada, David, Ramírez, Belén G, Mechoulam, R, Innamorato, Nadia, Cuadrado, Antonio, de Ceballos, María L

    Published in Molecular pharmacology (01-06-2011)
    “…Microglial activation is an invariant feature of Alzheimer's disease (AD). It is noteworthy that cannabinoids are neuroprotective by preventing β-amyloid…”
    Get more information
    Journal Article
  8. 8

    Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease by Rojo, Ana I., Innamorato, Nadia G., Martín-Moreno, Ana M., De Ceballos, María L., Yamamoto, Masayuki, Cuadrado, Antonio

    Published in Glia (01-04-2010)
    “…Neural injury leads to inflammation and activation of microglia that in turn may participate in progression of neurodegeneration. The mechanisms involved in…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Sex Differences in Hypothalamic Changes and the Metabolic Response of TgAPP Mice to a High Fat Diet by Freire-Regatillo, Alejandra, Diaz-Pacheco, Sonia, Frago, Laura M., Arévalo, María-Ángeles, Argente, Jesús, Garcia-Segura, Luis M., de Ceballos, María L., Chowen, Julie A.

    Published in Frontiers in neuroanatomy (26-07-2022)
    “…The propensity to develop neurodegenerative diseases is influenced by diverse factors including genetic background, sex, lifestyle, including dietary habits…”
    Get full text
    Journal Article
  11. 11

    Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists by Navarro-Dorado, Jorge, Villalba, Nuria, Prieto, Dolores, Brera, Begoña, Martín-Moreno, Ana M, Tejerina, Teresa, de Ceballos, María L

    Published in Frontiers in neuroscience (16-09-2016)
    “…There is evidence of altered vascular function, including cerebrovascular, in Alzheimer's disease (AD) and transgenic models of the disease. Indeed…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway by Gómez del Pulgar, Teresa, de Ceballos, Marı́a L., Guzmán, Manuel, Velasco, Guillermo

    Published in The Journal of biological chemistry (27-09-2002)
    “…Cannabinoids, the active components of marijuana and their endogenous counterparts, exert many of their actions on the central nervous system by binding to the…”
    Get full text
    Journal Article
  14. 14

    Functional responses to the cannabinoid agonist WIN 55,212-2 in neonatal rats of both genders: influence of weaning by Borcel, Erika, Pérez-Alvarez, Laura, de Ceballos, Marı́a L, Ramirez, Belén G, Marco, Eva M a, Fernández, Beatriz, Rubio, Marina, Guaza, Carmen, Viveros, M a-Paz

    Published in Pharmacology, biochemistry and behavior (01-07-2004)
    “…We have studied behavioural, biochemical and endocrine responses to the cannabinoid agonist WIN 55,212-2 (WIN) in neonatal rats, as well as the effects of…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    The AMP‐Activated Protein Kinase Is Involved in the Regulation of Ketone Body Production by Astrocytes by Blázquez, Cristina, Woods, Angela, De Ceballos, María L, Carling, David, Guzmán, Manuel

    Published in Journal of neurochemistry (01-10-1999)
    “…: The possible role of the AMP‐activated protein kinase (AMPK), a highly conserved stress‐activated kinase, in the regulation of ketone body production by…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Beta-amyloid25-35 inhibits glutamate uptake in cultured neurons and astrocytes: modulation of uptake as a survival mechanism by Fernández-Tomé, Paz, Brera, Begoña, Arévalo, María-Angeles, de Ceballos, María L

    Published in Neurobiology of disease (01-04-2004)
    “…Glutamate transporters are vulnerable to oxidants resulting in reduced uptake function. We have studied the effects of beta-amyloid(25-35) (beta A(25-35)) on…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Impaired hippocampal glucoregulation in the cannabinoid CB1 receptor knockout mice as revealed by an optimized in vitro experimental approach by Lemos, Cristina, Valério-Fernandes, Ângela, Ghisleni, Gabriele C., Ferreira, Samira G., Ledent, Catherine, de Ceballos, María L., Köfalvi, Attila

    Published in Journal of neuroscience methods (15-03-2012)
    “…► We optimized a protocol to follow glucose uptake and metabolism in vitro. ► This method employs two types of radioactive glucose analogues. ► Deoxyglucose is…”
    Get full text
    Journal Article
  20. 20